Drug Policy
Select item 22479042 [ ]1. Coping strategies used by patients infected with hepatitis C virus who are facing medication costs. Sanyal C, Ingram EL, Sketris IS, Peltekian KM, Kirkland S. Can J Hosp Pharm. 2011 Mar;64(2):131-40. PMID: 22479042 |
| Groves KEM, Schellinck T, Sketris I, MacKinnon N. Identifying early prescribers of cycloxygenase-2 inhibitors (COX-2s) in Nova Scotia, Canada: Considerations for targeted academic detailing. [PDF - 169 kB]Research in Social and Administrative Pharmacy. 2009. |
| Ackroyd-Stolarz S, MacKinnon NJ, Sketris I, Sabo B. Potentially Inappropriate Prescribing of Benzodiazepines for Older Adults and Risk of Falls During a Hospital Stay: A Descriptive Study. [PDF - 174 kB] Canadian Journal of Hospital Pharmacy. 2009; 62(4): 276-83. |
| The National Pharmaceuticals Strategy: Rest in peace, revive or renew? [PDF - 158 kB]MacKinnon NJ, Ip I. Canadian Medical Association Journal. 2009; 180(8): 801-3. |
| Impact of drug plan management policies in Canada: A systematic review. [PDF - 303 kB]Morrison A, MacKinnon NJ, Hartnell NR, McCaffrey KJ. Canadian Pharmacists Journal. 2008; 141(6): 332-338. |
| Medication Management: Perceptions and Opinions of Canadian Hospital Executives. [PDF - 346 kB]Neil J MacKinnon, Nicole R Hartnell, Colleen J Metge, Ingrid Sketris, and Jean-François Bussières C JHP – Vol. 61, No. 1 – January–February 2008 |
| Provincial drug plans: now there’s a minefield Data on provincial differences adds important perspective. [PDF - 266 kB]Neil J. MacKinnon CPJ/RPC • SEPTEMBER 2004, VOL. 137, NO. 7 |